Prolyl-endopeptidase supplementation has been proposed to favour gliadin degradation as an alternative treatment for coeliac disease (CD), although the real usefulness of this therapy in vivo is still under discussion. 1 However, our data point to alternative treatments aiming to modify the intestinal microbiota in patients with CD by the use of probiotics and/or prebiotics. We propose that the induction of gliadin proteolysis in the human gut might not be the solution but the origin of CD
To date, the only available treatment for celiac disease (CD) patients is a life-lasting gluten-free...
Background: Coeliac disease is caused by an immune response to gluten. As gluten proteins are prolin...
Celiac disease (CD) is a common chronic lifelong autoimmune enteropathy triggered by gluten intake i...
Adjunta Nota de Prensa del CSIC.Prolyl-endopeptidase supplementation has been proposed to favour gli...
The enzymopathic hypothesis of the aetiology of coeliac disease (CD) is still relevant as a mechanis...
Producción CientíficaThese results open the way for alternative therapies for Coeliac Disease based...
The primary pathogenic trigger in coeliac disease (CD) is still unknown. We present the hypothesis t...
AbstractCoeliac disease (CD) is an inflammatory disorder of the upper small intestine in which glute...
Dietary treatment of coeliac disease should be based on a sound theoretical knowledge of the differe...
Disaccharidases (DS) are brush border enzymes embedded in the microvillous membrane of small intesti...
Purpose Although genetic predisposition and exposure to dietary gluten are considered necessary trig...
Coeliac disease (CD) is associated with alterations of the intestinal microbiota. Although several B...
Celiac disease (CD) is an immune-mediated enteropathy that occurs in genetically predisposed individ...
Celiac disease (CD) is an autoimmune enteropathy caused by an intolerance to gluten proteins. It has...
Celiac disease (CD) is an inflammatory autoimmune disorder resulting from the combination of genetic...
To date, the only available treatment for celiac disease (CD) patients is a life-lasting gluten-free...
Background: Coeliac disease is caused by an immune response to gluten. As gluten proteins are prolin...
Celiac disease (CD) is a common chronic lifelong autoimmune enteropathy triggered by gluten intake i...
Adjunta Nota de Prensa del CSIC.Prolyl-endopeptidase supplementation has been proposed to favour gli...
The enzymopathic hypothesis of the aetiology of coeliac disease (CD) is still relevant as a mechanis...
Producción CientíficaThese results open the way for alternative therapies for Coeliac Disease based...
The primary pathogenic trigger in coeliac disease (CD) is still unknown. We present the hypothesis t...
AbstractCoeliac disease (CD) is an inflammatory disorder of the upper small intestine in which glute...
Dietary treatment of coeliac disease should be based on a sound theoretical knowledge of the differe...
Disaccharidases (DS) are brush border enzymes embedded in the microvillous membrane of small intesti...
Purpose Although genetic predisposition and exposure to dietary gluten are considered necessary trig...
Coeliac disease (CD) is associated with alterations of the intestinal microbiota. Although several B...
Celiac disease (CD) is an immune-mediated enteropathy that occurs in genetically predisposed individ...
Celiac disease (CD) is an autoimmune enteropathy caused by an intolerance to gluten proteins. It has...
Celiac disease (CD) is an inflammatory autoimmune disorder resulting from the combination of genetic...
To date, the only available treatment for celiac disease (CD) patients is a life-lasting gluten-free...
Background: Coeliac disease is caused by an immune response to gluten. As gluten proteins are prolin...
Celiac disease (CD) is a common chronic lifelong autoimmune enteropathy triggered by gluten intake i...